ENDRA Life Sciences Q3 EPS $(1.02) Misses $(0.84) Estimate

Benzinga · 2d ago
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.84) by 21.43 percent. This is a 51.43 percent increase over losses of $(2.10) per share from the same period last year.